Arquivamento - Art. 36 §1° da LPI
#11.2
11/18/2025
RPI 2863
Application data
Number
112021011386Type
Filing
Publication
PCT
US2019066150 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 11/18/2025. We update with every new RPI gazette, published weekly.
Applicants
AUSPEX PHARMACEUTICALS, INC
US
Inventors
F. S. (pessoa física)
DE
J. S. (pessoa física)
CH
M. G. (pessoa física)
US
IPC Classification
Priority claims
US
62/779,232 · 12/13/2018
US
62/801,450 · 02/05/2019
Abstract
DEUTETRABENAZINA PARA O TRATAMENTO DA DISCINESIA NA PARALISIA CEREBRAL.A divulgação é direcionada a métodos de tratamento de discinesia em paralisia cerebral em pacientes humanos usando deutetrabenazina e seus metabólitos ativos.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
11/18/2025
RPI 2863
#6.23
07/22/2025
RPI 2846
#1.3
08/31/2021
RPI 2643
#1.1
06/22/2021
RPI 2633
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.